Role for intracellular proteases in the processing and transport of class II HLA antigens
- PMID: 3287381
- PMCID: PMC280343
- DOI: 10.1073/pnas.85.11.3975
Role for intracellular proteases in the processing and transport of class II HLA antigens
Abstract
Human B-lymphoblastoid cell lines (B-LCL) incubated with the protease inhibitor leupeptin accumulate complexes of class II HLA antigens with a series of Mr 21,000-23,000 basic proteins termed leupeptin-induced proteins (LIP). The appearance of class II antigen-associated LIP coincides with the disappearance of class II antigen-associated invariant (I) chain. Glycopeptides generated by in vitro proteolysis of LIP and I chain using Staphylococcus aureus V8 protease are identical as determined by electrophoresis in sodium dodecyl sulfate. These results suggest that LIP is a proteolytic product derived from the I chain and are consistent with the view that further in vivo proteolysis of LIP by a leupeptin-sensitive enzyme normally facilitates its release from class II antigens. Incubation of B-LCL with monensin, which traps class II antigens and associated I chain in the Golgi apparatus, or chloroquine, which neutralizes intracellular acidic compartments and inhibits I-chain dissociation, blocks the leupeptin-induced appearance of LIP. Treatment of LIP with endoglycosidases F and H shows that both of its N-linked oligosaccharides are in the complex form, indicating that proteolysis of class II antigen-associated I chain to generate LIP occurs in a late-Golgi or post-Golgi compartment. The compartment in which these proteolytic events occur may be identical to the site in macrophages and B lymphocytes where foreign antigens are processed and interact with class II HLA molecules.
Similar articles
-
Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo.J Immunol. 1993 Oct 15;151(8):4153-63. J Immunol. 1993. PMID: 8409392
-
HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.J Immunol. 1996 Dec 15;157(12):5487-95. J Immunol. 1996. PMID: 8955198
-
Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.Proc Natl Acad Sci U S A. 1984 Mar;81(5):1287-91. doi: 10.1073/pnas.81.5.1287. Proc Natl Acad Sci U S A. 1984. PMID: 6608726 Free PMC article.
-
Intracellular transport and peptide binding properties of HLA class II glycoproteins.Semin Immunol. 1990 Jul;2(4):273-80. Semin Immunol. 1990. PMID: 2104276 Review.
-
Biosynthesis and processing of class II histocompatibility antigens.Crit Rev Immunol. 1987;7(1):31-53. Crit Rev Immunol. 1987. PMID: 3545672 Review.
Cited by
-
Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain.J Cell Biol. 1991 Dec;115(5):1213-23. doi: 10.1083/jcb.115.5.1213. J Cell Biol. 1991. PMID: 1955469 Free PMC article.
-
Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1056-61. doi: 10.1073/pnas.95.3.1056. Proc Natl Acad Sci U S A. 1998. PMID: 9448284 Free PMC article.
-
Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles.J Exp Med. 1995 May 1;181(5):1729-41. doi: 10.1084/jem.181.5.1729. J Exp Med. 1995. PMID: 7722451 Free PMC article.
-
Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2282-6. doi: 10.1073/pnas.89.6.2282. Proc Natl Acad Sci U S A. 1992. PMID: 1549594 Free PMC article.
-
Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.Cell Regul. 1990 Jun;1(7):499-509. doi: 10.1091/mbc.1.7.499. Cell Regul. 1990. PMID: 2098113 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials